What to Know When Preparing to Pitch

By Rory McCann, Director of Marketing, Conference Producer, LSN

The RESI Boston Innovator’s Pitch Challenge is now accepting applications! RESI is a leader in connecting early-stage companies with capital and licensing partners, but it’s the founders that present and pitch their way to success. Whether a first-time founder or a veteran, pitching can be daunting, but knowing how to speak to investors can give a founder an edge over a competing company. We’ve compiled a brief list of what-to-knows to help founders prepare for a successful pitch:

  1. Know your audience. Who are you pitching to? What are their concerns and pain points that you can address? For instance, a VC may have different questions than an angel or family office. Additionally, are they specific to your sector or technology? Understanding their background with your product will help you tailor how you present the information in a way that they comprehend.
  2. Know your format. Is this a warm introduction, cold call, or a pitch competition with limitations on how long you can speak for? Do you bring slides or share them ahead? Is it in-person or some virtual platform you need prior experience with? Knowing the format of the pitch is valuable because it saves precious time and shows investors that you are prepared.
  3. Know your presentation. Make sure you are comfortable with the points you’re hitting and the amount of time you plan to spend on each point. We recommend that pitching companies touch on their product or tech, team, company model, existing traction, market landscape, go-to-market strategy, and of course, the raise ask and how it’s to be used. Practice these points so you are confident in your presentation and comfortable fielding questions.

Want to put these tools to the test? Join us September 21-22 for the onsite Innovator’s Pitch Challenge at RESI Boston. Applications are accepted on a rolling basis, so get yours in soon!

RESI-Boston-2022-Banner - new - 1100px

RESI Boston Pitch Applications Now Open

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

One of the best parts of RESI returning to an in-person format after more than two years is the return of the live pitch session! RESI Boston returns in-person September 21-22, with an additional day of dedicated-digital partnering September 23. Applications to pitch for the Innovator’s Pitch Challenge (IPC) are now open until Friday, August 12! The IPC was created to respond to the need for a digital pitch format. Now it has been modified to bring the value and function to an in-person format.

What Is It?
The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage life science and healthcare companies to gain additional exposure to conference attendees and pitch directly to a panel of judges, featuring active investors and industry experts. Participating companies pay to host their company materials on the Live Agenda and participate in the live pitch session.

How Does It Work?
Pitching companies will have a dedicated webpage on the RESI Live Agenda, which greatly increases visibility to investors and other registered attendees. Companies can share their marketing collateral such as their slide deck, executive summary, optional pitch video, and more.

Each pitching company will be assigned to an IPC session, with each session featuring four companies, grouped together based on similar sector and/or technology. Companies will be given four minutes to pitch, followed by an additional ten minutes of Q&A and feedback from the judging panel.

Who Should Apply?
Early-stage life science companies actively raising seed capital ($25K – 2M), Series A ($2 – 10M), or Series B ($10 – 50M) use the IPC to get in front of the panel of qualified investor judges in their market segment and pitch their company and product. Early-stage companies are encouraged to apply and submit their pitch deck and executive summary.

Apply-for-the-IPC

RESI-Boston-2022-Banner - new - 1100px

Branding Opportunities at RESI Boston

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

RESI returns to an in-person format after more than two years this September, and now is the time to start planning exhibit and sponsorship engagements to hundreds of RESI attendees at the hub of life science industry – Boston, MA. Whether service providers increasing deal pipeline, big pharma sourcing technology assets, or just looking to connect with early-stage startups at pre-clinical/phase I stage, RESI Boston is the place to get started! With 350+ life science investors and big pharma, 200+ early-stage company executives, and dozens of delegations from global incubators, universities, and organizations, there’s no better place to connect with ideal partners and start those meaningful conversations.

To showcase products and services, RESI offers a range of sponsorship opportunities, including dedicated workshops, exhibition tables, and newsletter interviews. Prominent logo displays throughout both the digital platform and onsite signage will greatly increase brand visibility, as well as program guide ads, onsite meal or material sponsorship, session signage, pitch judging, and more.

Check out sponsorship opportunities for RESI Boston, September 21-23. For more information about sponsorship, advertising, and exhibit opportunities, contact our dedicated BD team. We look forward to helping you meet your goals!

LSN_OnsiteSponsorshipBrochure_06232022-1

RESI-Boston-2022-Banner - new - 1100px

Tech Hub Exposure at RESI Boston

By Erika Wu, Business Development Manager, Global Tech Hubs, LSN

RESI Boston returns to an in-person format this September, and if you’re part of a tech hub, RESI is the place to be! Join RESI’s global tech hub ecosystem of accelerators, incubators, non-profits, universities, tech transfer offices, and regional organizations who set up their early-stage life science startup constituents for success with their entrepreneurship journey. Recently, RESI has hosted tech hubs ranging from National Institute of Aging (NIA), The Massachusetts Medical Device Development Center (M2D2), Government of Ontario, Yale Ventures, and more.

Through RESI partnership, tech hub startup constituents gain access to resources beyond partnering with investors and strategic partners, such as the Life Science Nation (LSN)’s Investor Database, Innovator’s Pitch Challenge (IPC), free workshops, and Entrepreneurial Immersion Courses, to help develop compelling marketing materials, build meaningful relationships with investors and secure necessary early-stage funding.

At RESI Boston, tech hub organizations and their startup constituents who’ve raised less than $2M can utilize:

  • 50% discount for startup constituent registration (startup must be from LSN’s tech hub partners)
  • Complimentary tech hub staff registration
  • Group Fundraising Investor Database Package (3 startups minimum): 4-month access to the Investor Database
  • Dedicated onsite-only Innovator’s Pitch Challenge (IPC) session
  • Exhibition space

If you’re a member of a tech hub or looking to add value to your members, reach out to see which offerings best fit your needs. From lab to clinic, and providers to patients, LSN is accelerating the growth and success of companies emerging from tech hubs.

For more information about tech hub offer, please contact Erika Wu, Business Development Manager, Global Tech Hubs at e.wu@lifesciencenation.com.

RESI-Boston-2022-Banner - new - 1100px

Digital RESI June IPC Winners

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

At Digital RESI June, nearly 50 life science and healthcare startups participated in the Innovator’s Pitch Challenge (IPC), a unique pitching opportunity for early-stage companies in therapeutics, medical device, diagnostics, digital health, and R&D/services sectors.

All attendees are encouraged to participate in viewing each finalist’s dedicated webpage, pitching materials, and live session in order to vote for the best pitch at RESI. Everyone from fellow startup founders to active early-stage investors votes for their favorite companies based on the materials displayed on their dedicated landing pages (pitch video, slide deck, executive summary, etc.) as well as their performance in live Q&A sessions, in which founders pitch directly to and participate in a subsequent Q&A with investor judges.

Life Science Nation is pleased to share the winners of last week’s IPC who received the most votes during the 3-day conference. Congratulations to the winners! Check them out below and see the full list of finalists. The IPC returns to an in-person format September 21-22 at RESI Boston! Contact us to learn more and apply.

Surgical Automations, Inc. – First Place
We are building the Tesla for endoscopic procedures. We are developing Automated Endoscopic Robots for procedures such as Upper and Lower GI endoscopy, Cystoscopy and Ureteroscopy, Endotracheal Intubation and Bronchoscopy. Our core technology is AI based Automated Robotic Endoluminal Navigation (AREN) and is supplemented by an IoT infrastructure that enables us to offer an integrated stakeholder experience to patients, physicians and the hospital leadership. The automated scanning of the anatomy is performed in a predetermined fashion ensuring all areas are visualized. During scanning, our AI/ML algorithms that are developed after extensive training on the images, identify the target anatomy and screen for any visual abnormality. If identified and when indicated, the robot will recommend the procedure to perform. Upon confirmation from the physician, the robot will mark a trajectory on the lesion predicting the exact location where the intervention will be done. Upon confirmation from the physician, the robot will perform the procedure. All this is automated and done under the supervision of the physician who has the capability to manually override at any time. Additionally, in addition to providing us with important data for business analytics, the IoT infrastructure and data warehouse also offers value-added interactive interfaces to our stakeholders for a superior experience and engagement.

JOCAVIO Co. Ltd. – Second Place
JOCAVIO Co. Ltd. was founded in 2021 by Drs. Tomoko and Hiroyuki Inoue together with seasoned industry experts in 2021 with a vision to provide “Hope for the Irreplaceable Lives of Cancer Patients”. JOCAVIO’s core expertise is genetic manipulation of vaccinia virus and the unique coating technology that enable repeated systemic administration of virus vectors. Moreover, we utilize a promising nanobody technology that allows multi-epitope binding for cancer specific tropism. Our primary focus is a novel oncolytic virus that provides not only robust efficacy with multiple targets but also possesses a “kill switch” that inhibits virus replication in case of excess activity. Utilizing our expertise on vaccinia virus, we have a project on SARS-Cov-2 vaccine that would be effective regardless of different variants. This project is an expedited project in needs of effective vaccines and will enter FIH in 3Q 2023 and we expect to complete P2 in 2024. Similarly, some early pipelines in consideration include vaccines that are effective for Zika and Dengue fever. We are looking for investors to help us in seed finance to support FIH in 2024-2025. Also we are keen on a strategic partnership with companies who are interested in co-development of our vaccine projects in APAC countries.

SynCell Biotechnology, Inc. – Third Place
SynCell’s business is focused on making the cutting edge a reality, offering a pipeline of novel antimicrobial products from our patented platform that improves patients’ quality of life, enhances the quality of care, and reduces the burden on society from the costs of antimicrobial resistance.

Register-now-button-new

RESI-Boston-2022-Banner - new - 1100px

RESI Boston Panels

By Caitlin Dolegowski, Marketing Specialist, LSN

The Redefining Early Stage Investment (RESI) conference series returns in-person to the Westin Copley Place in Boston, MA  September 21-22, with September 23 dedicated to virtual partnering available to in-person and virtual attendees. While the platform for hosting will change, the panels will continue to feature investors, industry experts, and seasoned entrepreneurs providing valuable insight to our conference attendees.

RESI Boston will feature fourteen live panels over two days onsite. The agenda features investor panels (Angels, Family Offices, Corporate Venture Capital) with focus on relevant topics in the life science industry with panels like Oncology Innovation, Medical Devices, Big Pharma, and Digital Health. Life Science Nation’s Tales from the Road panels will also highlight startup founders and entrepreneurs sharing their stories of success along the fundraising journey. This conference will also host panels dedicated to the AI and Longevity sectors, sharing these areas of life science with increasing traction.

As we are transitioning into a hybrid format, these panels will be live and available to view on our live agenda for two weeks after the conference. Register by July 1 to save $500 on super early bird rates.

RESI Boston Preliminary Agenda
Sept. 21 – Wednesday Sept. 22 – Thursday
9 AM EDT Angels
Explaining the Process of Engagement
Digital Health
Leveraging Software, Lowering Costs & Improving Care
10 AM EDT Medical Devices
Investing in Novel Engineering
Big Pharma
Strategies for Preclinical & Early Clinical Assets
11 AM EDT Tales from the Road
The Fundraising Biotech Founder
Tales from the Road
Medtech Startups Redefining Possibility
12 PM EDT Lunch
1 PM EDT Diagnostics
Next-Gen Tech Changing Treatment Paradigms
Corporate VC
The Changing Landscape & New Opportunities
2 PM EDT Tales from the Road
AI at the Intersection of Health and Tech
AI Healthcare Investments
Defining Tech and Discovering Potential
3 PM EDT New, Now, and Next in Longevity Investment
Opportunity and Priorities in Age-Tech
Tales from the Road
Age-Tech Innovators on Their Fundraising Journey
4 PM EDT Family Offices
Perspectives on Seed & Series A Rounds
Oncology Innovation
The Search for New Approaches to Diagnosing & Treating Cancer
5 PM EDT Networking Reception

RESI-Boston-2022-Banner - new - 1100px

The 4 Fs of Successful Meetings

By Rory McCann, Director of Marketing, Conference Producer, LSN

Last week, Life Science Nation (LSN) wrapped up Digital RESI June, its most recent virtual partnering event. As we look ahead to our first in-person partnering conference in over two years, we want to first discuss how to evaluate the success of previous meetings. You’ve done your research, messaged investors, and booked meetings, but after the curtain falls, how do you measure the success of your partnering?

  1. Fit
    1. Was the meeting well-matched between a company and an investor who were matched in product and stage of development?
    2. Did they make any references to existing interest or past investments?
    3. Did they connect you with other peers or colleagues?
  2. Feel
    1. Was the atmosphere pleasant and enjoyable?
    2. Were you confident answering questions and did the potential partner seem equally satisfied?
    3. Is this someone you would enjoy working with more closely?
  3. Follow-Up
    1. Do they want to have a follow-up meeting?
    2. Did they express interest in signing an NDA?
    3. Did they engage you during networking activities and receptions?
  4. Feedback
    1. Did you receive insights on your pitch, technology, or market?
    2. Was the feedback knowledgeable and relevant?
    3. Will it contribute to your future fundraising efforts?

While the success of a meeting isn’t based on an affirmative answer to each question, your honest response to each can help gauge the temperature of your meetings. A negative answer isn’t the definition of failure, either. It’s all data. Coming away from a well-fitting meeting without the feeling that the person or firm is one you’d like to work and spend more time with is valuable and worth further consideration. This is truly what makes successful meetings – not only the quality of the meeting itself but also the valuable information you need to make informed decisions moving forward.

Keep the conversations going and sign up for RESI Boston! Learn more about travel and accommodations and save on super early bird rates!

RESI-Boston-2022-Banner - new - 1100px